These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11567745)

  • 1. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.
    Finerty S; Stokes CR; Gruffydd-Jones TJ; Hillman TJ; Barr FJ; Harbour DA
    Vaccine; 2001 Oct; 20(1-2):49-58. PubMed ID: 11567745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
    AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal infection and vaccination against feline immunodeficiency virus.
    Stokes CR; Finerty S; Gruffydd-Jones TJ; Sturgess CP; Harbour DA
    J Biotechnol; 1999 Aug; 73(2-3):213-21. PubMed ID: 10486930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
    Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against feline immunodeficiency virus using fixed infected cells.
    Verschoor EJ; van Vliet AL; Egberink HF; Hesselink W; van Alphen WE; Joosten I; Boog CJ; Horzinek MC; de Ronde A
    Vet Immunol Immunopathol; 1995 May; 46(1-2):139-49. PubMed ID: 7618254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.
    Flynn JN; Cannon CA; Neil JC; Jarrett O
    J Virol; 1997 Oct; 71(10):7586-92. PubMed ID: 9311839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
    Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus.
    Stevens R; Howard KE; Nordone S; Burkhard M; Dean GA
    J Virol; 2004 Aug; 78(15):8210-8. PubMed ID: 15254192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
    Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
    Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge.
    Finerty S; Stokes CR; Gruffydd-Jones TJ; Hillman TJ; Reeves NA; Whiting CV; Schaaper WM; Dalsgaard K; Harbour DA
    Vaccine; 2000 Aug; 18(28):3254-65. PubMed ID: 10869770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts.
    Giannecchini S; Isola P; Sichi O; Matteucci D; Pistello M; Zaccaro L; Del Mauro D; Bendinelli M
    J Virol; 2002 Jul; 76(14):6882-92. PubMed ID: 12072489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines.
    Siebelink KH; Tijhaar E; Huisman RC; Huisman W; de Ronde A; Darby IH; Francis MJ; Rimmelzwaan GF; Osterhaus AD
    J Virol; 1995 Jun; 69(6):3704-11. PubMed ID: 7745719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection.
    Hosie MJ; Flynn JN
    J Virol; 1996 Nov; 70(11):7561-8. PubMed ID: 8892875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells.
    Karlas JA; Siebelink KH; v Peer MA; Huisman W; Rimmelzwaan GF; Osterhaus AD
    Vet Immunol Immunopathol; 1998 Oct; 65(2-4):353-65. PubMed ID: 9839884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets.
    Hofmann-Lehmann R; Holznagel E; Aubert A; Bauer-Pham K; Lutz H
    Vet Immunol Immunopathol; 1995 May; 46(1-2):115-25. PubMed ID: 7618251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
    Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.
    Toyosaki T; Miyazawa T; Furuya T; Tomonaga K; Shin YS; Okita M; Kawaguchi Y; Kai C; Mori S; Mikami T
    Arch Virol; 1993; 131(3-4):335-47. PubMed ID: 8102229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
    Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
    J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement after feline immunodeficiency virus vaccination.
    Hosie MJ; Osborne R; Reid G; Neil JC; Jarrett O
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):191-7. PubMed ID: 1337397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.